18
GALSTYAN AND LANE
Table 2: Real Exchange Rates: Long-Run Behavior
|
(1) |
(2) |
(3) |
(4) |
(5) |
(6) | |
|
Rel. Govt. Consumption |
1.64 |
2.70 |
1.64 |
1.77 |
2.17 |
1.63 |
|
(.47)*** |
(1.34)** |
(.40)*** |
(.40)*** |
(1.52) |
(.46)*** | |
|
Rel. Govt. Investment |
-0.64 |
-8.02 |
-1.06 |
-0.99 |
1.13 |
-1.28 |
|
(1.23) |
(4.85) |
(1.14) |
(1.12) |
(2.53) |
(1.37) | |
|
Rel. GDP per capita |
0.31 |
0.48 |
0.28 |
0.23 |
0.40 |
0.19 |
|
(.09)*** |
(.80) |
(.08)*** |
(.09)*** |
(.26) |
(.10)* | |
|
Trade Balance |
-1.15 |
-0.50 |
-0.99 |
-1.26 |
-1.54 |
-1.24 |
|
(.20)*** |
(1.11) |
(.21)*** |
(.24)*** |
(.54)*** |
(.30)*** | |
|
R2 |
0.61 |
0.62 |
0.55 |
0.53 |
0.29 |
0.59 |
|
Marginal R2 |
0.14 |
0.29 |
0.15 |
0.23 |
0.26 |
0.24 |
|
Observations |
418 |
66 |
352 |
242 |
88 |
154 |
|
Sample |
All |
G3 |
Non-G3 |
EMU |
E4 |
Non-E4 |
Note: Real effective exchange rate is computed by the authors using trade shares pro-
vided by Bayoumi et al (2005) using the set of countries listed in Appendix A; ln stands
for natural logarithm; Rel. Govt. Consumption is relative government consumption as
a share of GDP; Rel. Govt. Investment is relative government investments as a share of
GDP; Rel. GDP per capita is the log of real relative GDP per capita; Trade Balance is the
trade balance as a share of GDP.
Marginal R2 is constructed by subtracting the ratio of the residual sum of squares of fixed
effects regression with the set of control variables over the residual sum of square of the
regression on the fixed effects only from one.
***,**,* significant at 1,5 and 10 percent respectively.
More intriguing information
1. Fiscal Reform and Monetary Union in West Africa2. Food Prices and Overweight Patterns in Italy
3. The name is absent
4. The name is absent
5. How we might be able to understand the brain
6. A Bayesian approach to analyze regional elasticities
7. The Clustering of Financial Services in London*
8. Assessing Economic Complexity with Input-Output Based Measures
9. TECHNOLOGY AND REGIONAL DEVELOPMENT: THE CASE OF PATENTS AND FIRM LOCATION IN THE SPANISH MEDICAL INSTRUMENTS INDUSTRY.
10. The name is absent